Jun Liu

Chairman at CHANGZHOU QIANHONG BIOPHARMA CO.,LTD

Net worth: 17 M $ as of 30/05/2026

59 year

Health Technology

Profile

Jun Liu currently works at Changzhou Qianhong Biopharma Co., Ltd., as Chairman-Supervisory Board from 2024, Zonhon Biopharma Institute, Inc., as Director from 2015, and Aucentra Therapeutics Pty Ltd., as Director.
Mr. Liu also formerly worked at Changzhou Bio-pharma Qianhong Co. Ltd., as Director-Supervisory Board and Jiangsu Biological Technology Association, as Member.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CHANGZHOU QIANHONG BIO-PHARMA CO., LTD. 5.04%	29/09/2025	18,044,733 ( 5.04% )	17 M $	30/05/2026

Jun Liu active positions

Companies	Position	Start
CHANGZHOU QIANHONG BIOPHARMA CO.,LTD	Chairman	18/01/2024
Zonhon Biopharma Institute, Inc.	Director/Board Member	08/02/2015
Aucentra Therapeutics Pty Ltd. Aucentra Therapeutics Pty Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops anti-cancer drugs	Director/Board Member	-

All active positions of Jun Liu

Former positions of Jun Liu

Companies	Position	End
Changzhou Bio-pharma Qianhong Co. Ltd.	Director/Board Member	-
Jiangsu Biological Technology Association	Corporate Officer/Principal	-

See the detail of Jun Liu's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jun Liu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Changzhou Qianhong Biopharma Co., Ltd. Changzhou Qianhong Biopharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures & sells pharmaceutical products	Health Technology
Jiangsu Biological Technology Association
Changzhou Bio-pharma Qianhong Co. Ltd.
Zonhon Biopharma Institute, Inc.
Aucentra Therapeutics Pty Ltd. Aucentra Therapeutics Pty Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops anti-cancer drugs	Health Technology